Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism

Otolaryngology - Head and Neck Surgery

Volumn 118, Issue 5, 1998, Pages 597-602

  Weisman, R A ^a   Christen, R ^a   Los, G ^a   Jones, V ^a   Kerber, C ^a   Seagren, S ^a   Glassmeyer, S ^a   Orloff, L A ^a   Wong, W ^a   Kirmani, S ^a   Howell, S ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; RETINOIC ACID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG POTENTIATION; FEMALE; HEAD AND NECK CANCER; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INJECTIONS, INTRA-ARTERIAL; ISOTRETINOIN; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031948025     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0194-5998(98)70227-X     Document Type: Article

References (24)

1. DE Schuller B Meatch DW Mattox Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group Laryngoscope 98 1988 1205 1211
2. Head and Neck Contracts Program Adjuvant chemotherapy for advanced head and neck squamous carcinoma Cancer 60 1987 301 311
3. AA. Forastiere Randomized trials of induction chemotherapy Hematol Oncol Clin North Am 5 1991 725 736
4. WM. Hryniuk The importance of dose intensity in the outcome of chemotherapy S Hellman V DeVita S Rosensberg Advances in oncology. 1988 JB Lippincott Philadelphia 121 141
5. L Levin W. Hryniuk Dose intensity analysis of chemotherapy regimens in ovarian carcinoma J Clin Oncol 5 1987 756 767
6. S. Carter Single and combination nonhormonal chemotherapy in breast cancer Cancer 30 1972 1543 1555
7. JK Samson SE Rivkin SE Jones Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer: a Southwest Oncology Group (SWOG) project Cancer 53 1984 1029 1035
8. F Cavalli RW Sonntag F Jungi VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules Cancer Treat Rep 62 1978 473 475
9. WM Hyriniuk A Figuerdo M. Goodyear Application of dose intensity to problems in chemotherapy of breast and colorectal cancer Semin Oncol 14 1987 3 11
10. VA Marcial TF Pajak M Mohjuddin Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck Cancer 66 1990 1861 1868
11. DJ Adelstein VM Sharan AS Earle Long term results after chemoradiotherapy for locally confined squamous cell head and neck cancer Am J Clin Oncol 13 1990 440 447
12. DJ Adelstein LA Kalish GL Adams Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an eastern cooperative oncology group pilot study J Clin Oncol 11 1993 21236 21422
13. M Al-Sarraf M Le Blanc PGS Giri Superiority of chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (Pts) with locally advanced nasopharyngeal cancer (NPC): preliminary results of intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) randomized study [abstract] Proc Am Soc Clin Oncol 15 1996 313
14. KT Robbins D Vicario S Seagren A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer Am J Surg 168 1994 419 422
15. S Aebi R Kroening JA Jones All-trans retinoic acid enhances the activity of cisplatin in head and neck cancer and ovarian cancer cell lines Proc Am Assoc Cancer Res 3 1997 2033 2038
16. F Meyskens E Gilmartin G Alberts Activity of isotretinoin against squamous cell cancers and preneoplastic lesions Cancer Treat Rep 66 1982 1315 1319
17. KS Hong S Lippman L Itri Prevention of secondary primary tumors with isotretinoin in squamous cell carcinoma of the head and neck N Engl J Med 323 1990 795 801
18. R Warrell S Frankel WWE Miller Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid) N Engl J Med 324 1991 1385 1393
19. S Lippman F. Meyskens Treatment of advanced squamous cell carcinoma of the skin with isoretinoin Ann Intern Med 107 1987 499 502
20. K Kraemer J DiGiovanna A Moshell Prevention of skin cancer in xeroderma pigmentosum with the use of oral isoretinoin N Engl J Med 318 1988 1633 1637
21. S Lippman J Kessler M Al-Sarraf Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial Invest New Drugs 6 1988 51 56
22. T Otkawa K Hirotani O Nakamura A highly potent antiangiogenic activity of retinoids Cancer Lett 48 1989 157 162
23. MA Smith DR Parkinson BD Cheson Retinoids in cancer therapy J Clin Oncol 10 1992 839 864
24. KT Robbins AM Storniolo C Kerber Rapid superselective high dose cisplatin infusion for advanced head and neck malignancies Head Neck Surg 14 1992 364 371